The finding that high levels of IL-34 are associated with better prognosis in certain breast cancer subtypes is surprising, since the expression of CSF-1 and the common receptor CSF-1R has been linked to aggressive behavior and poor prognosis in breast cancer patients[29, 35–37]. This evidence concerns the gene IL34 and breast carcinoma.